Home  /  Latin America and the Caribbean  /  JAM

Jamaica

Jamaica appears only through international and donor bodies that compile figures across many countries, and no figures for the country are read directly from a national publisher. PEPFAR's results for the country are broken down by province and count only the sites PEPFAR supports. The assessment of national sources, country by country, is set out on the Methods page.

28,000
People living with HIV, 2025
WHO Global Health Observatory
52.0%
On antiretroviral treatment, 2025
WHO Global Health Observatory
$2.4m
United States HIV disbursements, 2026
ForeignAssistance.gov
$14.6m
External HIV financing, all donors, 2024
OECD Creditor Reporting System
External HIV financing
OECD CRS · ForeignAssistance.gov
$0$10m$20m200220052008201120142017202020232026$14.6m$7.8m$6.7m$2.4m
  • All donors
  • United States, OECD record
  • The Global Fund
  • United States, self-reported
YearAll donorsUnited States, OECD recordThe Global FundUnited States, self-reported
2002 $980k $594k — $387k
2003 $2.1m $1.5m — $1.3m
2004 $3.6m $1.1m $2.2m $1.2m
2005 $4.9m $608k $3.5m $754k
2006 $7.4m $577k $5.9m $796k
2007 $7.8m $1.4m $4.7m $1.2m
2008 $11.0m $1.8m $8.0m $1.8m
2009 $10.4m $469k $9.4m $772k
2010 $14.5m $2.3m $11.7m $1.7m
2011 $16.4m $6.7m $8.9m $6.4m
2012 $8.4m $4.4m $3.2m $4.9m
2013 $13.9m $4.4m $8.4m $4.5m
2014 $5.0m $4.8m — $4.7m
2015 $7.0m $3.0m $3.2m $3.8m
2016 $9.7m $3.7m $5.3m $2.7m
2017 $11.7m $5.3m $5.2m $5.8m
2018 $9.4m $5.3m $3.9m $5.4m
2019 $9.1m $4.7m $4.3m $4.5m
2020 $10.5m $6.2m $4.2m $5.1m
2021 $8.1m $6.4m $1.6m $5.9m
2022 $21.8m $13.7m $8.0m $13.4m
2023 $11.8m $8.6m $2.8m $9.1m
2024 $14.6m $7.8m $6.7m $7.6m
2025 — — — $7.6m
2026 — — — $2.4m

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment
UNAIDS AIDSinfo
010k20k30k20002003200620092012201520182021202428,00015,000
  • People living with HIV
  • People on treatment
YearPeople living with HIVPeople living with HIV (lower)People living with HIV (upper)People on treatment
2000 29,000 25,000 33,000 —
2001 29,000 26,000 33,000 —
2002 30,000 27,000 33,000 —
2003 30,000 27,000 33,000 —
2004 30,000 27,000 33,000 —
2005 30,000 27,000 32,000 —
2006 29,000 27,000 32,000 —
2007 29,000 27,000 32,000 —
2008 29,000 27,000 32,000 —
2009 29,000 27,000 32,000 —
2010 29,000 27,000 32,000 5,800
2011 29,000 27,000 32,000 6,700
2012 29,000 27,000 32,000 7,500
2013 29,000 27,000 32,000 8,800
2014 29,000 27,000 32,000 9,500
2015 29,000 27,000 32,000 10,000
2016 29,000 27,000 31,000 11,000
2017 28,000 27,000 31,000 12,000
2018 28,000 27,000 31,000 13,000
2019 28,000 27,000 31,000 14,000
2020 28,000 27,000 31,000 13,000
2021 28,000 26,000 31,000 14,000
2022 28,000 26,000 31,000 15,000
2023 28,000 26,000 31,000 15,000
2024 28,000 26,000 31,000 15,000

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade
UNAIDS AIDSinfo
0%20%40%2010201220142016201820202022202454.0%50.0%
  • On treatment
  • Virally suppressed
YearOn treatmentVirally suppressed
2010 20.0% —
2011 23.0% 13.0%
2012 26.0% 15.0%
2013 30.0% 18.0%
2014 33.0% 21.0%
2015 35.0% 22.0%
2016 38.0% 24.0%
2017 42.0% 28.0%
2018 45.0% 32.0%
2019 50.0% 39.0%
2020 46.0% 38.0%
2021 50.0% 43.0%
2022 52.0% 47.0%
2023 53.0% 48.0%
2024 54.0% 50.0%

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

Sources of the figures for Jamaica

2,560 rows

SourceTypeRowsIndicators YearsRead fromRetrieved
UNICEF HIV/AIDS dataset Modelled estimate 867 4 2010–2025 sdmx.data.unicef.org 2026-10-20
UNAIDS AIDSinfo Programme record 493 21 2000–2024 aidsinfo.unaids.org 2026-10-20
PEPFAR results by province Programme record 232 7 2016–2025 data.pepfar.gov 2026-10-12
WHO Global Health Observatory Modelled estimate 217 10 2000–2025 ghoapi.azureedge.net 2026-10-12
WHO Global Tuberculosis Programme Programme record 115 12 2000–2024 extranet.who.int 2026-10-16
ForeignAssistance.gov Expenditure account 80 5 2002–2026 foreignassistance.gov 2026-10-29
Global Fund Data Service Programme record 73 6 2017–2025 fetch.theglobalfund.org 2026-10-12
OECD Creditor Reporting System Expenditure account 66 3 2002–2024 sdmx.oecd.org 2026-10-12
PEPFAR results by funding agency Programme record 64 9 2018–2025 data.pepfar.gov 2026-10-12
World Bank Open Data Modelled estimate 51 2 2000–2025 api.worldbank.org 2026-10-12
PAHO Core Indicators Programme record 48 1 2009–2024 opendata.paho.org 2026-10-13
IATI, through d-portal Expenditure account 44 3 2004–2026 d-portal.org 2026-10-12
PEPFAR testing by modality Programme record 44 6 2018–2025 data.pepfar.gov 2026-10-12
PEPFAR Panorama Spotlight Programme record 42 6 2018–2025 data.pepfar.gov 2026-10-12
PEPFAR budgets and expenditure Expenditure account 40 8 2021–2025 data.pepfar.gov 2026-10-12
PEPFAR commodity procurement plans Expenditure account 24 4 2020–2025 data.pepfar.gov 2026-10-12
WHO HIV testing services dashboard Programme record 21 5 2019–2024 eic-database-290813.ew.r.appspot.com 2026-10-14
UNAIDS Global AIDS Monitoring expenditure database Expenditure account 16 8 2013–2014 hivfinancial.unaids.org 2026-10-12
PAHO Interactive HIV Data Dashboard Programme record 15 2 2020–2025 paho.org 2026-10-14
Global Fund allocations Expenditure account 3 1 2017–2023 fetch.theglobalfund.org 2026-10-12
PEPFAR human resources for health inventory Expenditure account 3 3 2025 data.pepfar.gov 2026-10-12
PEPFAR operating-unit budgets Expenditure account 2 2 2020 data.pepfar.gov 2026-10-12

Indicators held

87 of 150

IndicatorDomainUnitRows YearsSourcesMost recent value
Country-reported HIV expenditure, all sources Financing USD 6 2012–2016 UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database $19.5m (2016)
Domestic funding received by the national TB programme Financing USD 1 2018 WHO Global Tuberculosis Programme $22k (2018)
Domestic public HIV expenditure Financing USD 2 2013–2014 UNAIDS Global AIDS Monitoring expenditure database $4.3m (2014)
Expected Global Fund funding for the national TB programme Financing USD 4 2019–2022 WHO Global Tuberculosis Programme $0 (2022)
Expected USAID funding for the national TB programme Financing USD 4 2019–2022 WHO Global Tuberculosis Programme $0 (2022)
Expected domestic funding for the national TB programme Financing USD 1 2019 WHO Global Tuberculosis Programme $55k (2019)
External HIV financing (all donors, ODA) Financing USD 23 2002–2024 OECD Creditor Reporting System $14.6m (2024)
External HIV financing from governments other than the United States (IATI) Financing USD 10 2009–2024 IATI, through d-portal $29 (2024)
External HIV financing from multilateral bodies other than the Global Fund (IATI) Financing USD 12 2015–2026 IATI, through d-portal $92k (2026)
External HIV financing from the United States (ODA) Financing USD 48 2002–2026 ForeignAssistance.gov, OECD Creditor Reporting System $2.4m (2026)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure Financing USD per three-year allocation cycle 3 2017–2023 Global Fund allocations 13,523,239 (2023)
Global Fund HIV disbursements to the country Financing USD 44 2004–2026 IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database $137k (2026)
Global Fund funding received by the national TB programme Financing USD 5 2017–2021 WHO Global Tuberculosis Programme $0 (2021)
International HIV expenditure (country-reported) Financing USD 2 2013–2014 UNAIDS Global AIDS Monitoring expenditure database $9.5m (2014)
Other bilateral HIV expenditure (country-reported) Financing USD 2 2013–2014 UNAIDS Global AIDS Monitoring expenditure database $15k (2014)
Out-of-pocket HIV expenditure by households Financing USD 2 2013–2014 UNAIDS Global AIDS Monitoring expenditure database $1.5m (2014)
PEPFAR expenditure, HHS/CDC Financing USD 5 2021–2025 PEPFAR budgets and expenditure $3.3m (2025)
PEPFAR expenditure, USAID Financing USD 5 2021–2025 PEPFAR budgets and expenditure $1.6m (2025)
PEPFAR expenditure, all US agencies Financing USD 8 2013–2025 PEPFAR budgets and expenditure, PEPFAR operating-unit budgets, UNAIDS Global AIDS Monitoring expenditure database $7.6m (2025)
PEPFAR expenditure, other US agencies Financing USD 5 2021–2025 PEPFAR budgets and expenditure $2.7m (2025)
PEPFAR planned commodity procurement, like for like Financing USD 6 2020–2025 PEPFAR commodity procurement plans $168k (2025)
PEPFAR planned funding (budget), all US agencies Financing USD 6 2020–2025 PEPFAR budgets and expenditure, PEPFAR operating-unit budgets $15.2m (2025)
PEPFAR planned funding, HHS/CDC Financing USD 5 2021–2025 PEPFAR budgets and expenditure $7.9m (2025)
PEPFAR planned funding, USAID Financing USD 5 2021–2025 PEPFAR budgets and expenditure $3.5m (2025)
PEPFAR planned funding, other US agencies Financing USD 5 2021–2025 PEPFAR budgets and expenditure $3.8m (2025)
PEPFAR planned procurement of antiretroviral drugs Financing USD 6 2020–2025 PEPFAR commodity procurement plans $0 (2025)
PEPFAR planned procurement of laboratory commodities Financing USD 6 2020–2025 PEPFAR commodity procurement plans $81k (2025)
PEPFAR planned procurement of rapid test kits Financing USD 6 2020–2025 PEPFAR commodity procurement plans $15k (2025)
PEPFAR spend on staff, human resources for health inventory Financing USD 1 2025 PEPFAR human resources for health inventory $5.8m (2025)
PEPFAR-funded staff delivering services, full-time equivalents Financing count 1 2025 PEPFAR human resources for health inventory 79 (2025)
PEPFAR-funded staff, full-time equivalents Financing count 1 2025 PEPFAR human resources for health inventory 176 (2025)
Private HIV expenditure (country-reported) Financing USD 2 2013–2014 UNAIDS Global AIDS Monitoring expenditure database $1.7m (2014)
US HIV disbursements managed by Health and Human Services Financing USD 16 2010–2026 ForeignAssistance.gov $1.5m (2026)
US HIV disbursements managed by USAID Financing USD 25 2002–2026 ForeignAssistance.gov $2k (2026)
US HIV disbursements managed by other US agencies Financing USD 8 2009–2016 ForeignAssistance.gov $0 (2016)
US HIV disbursements managed by the State Department Financing USD 6 2021–2026 ForeignAssistance.gov $861k (2026)
USAID funding received by the national TB programme Financing USD 5 2017–2021 WHO Global Tuberculosis Programme $0 (2021)
% of ALL PLHIV who are virally suppressed Treatment cascade percent 25 2011–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 48.0% (2025)
% of PLHIV on ART (second 95, PLHIV base) Treatment cascade percent 68 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 52.0% (2025)
% of PLHIV who have been diagnosed (first 95) Treatment cascade percent 2 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
% of estimated HIV-positive incident TB cases on TB treatment and ART Treatment cascade percent 20 2003–2024 UNAIDS AIDSinfo 47.8% (2024)
% of people newly enrolled in HIV treatment diagnosed with TB disease Treatment cascade percent 4 2020–2024 UNAIDS AIDSinfo 0.7% (2024)
% of people on ART who are virally suppressed (third 95) Treatment cascade percent 47 2015–2025 PEPFAR results by province, WHO Global Health Observatory 92.0% (2025)
% of returned HIV test results that were positive Treatment cascade percent 15 2019–2024 UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 1.1% (2024)
HIV self-test kits distributed Treatment cascade count 3 2022–2024 WHO HIV testing services dashboard 15,198 (2024)
HIV tests performed at a health facility Treatment cascade count 9 2019–2025 PEPFAR testing by modality, WHO HIV testing services dashboard 109 (2025)
HIV tests performed through community outreach Treatment cascade count 10 2018–2025 PEPFAR testing by modality, WHO HIV testing services dashboard 1,406 (2025)
HIV tests performed with the result returned to the person Treatment cascade count 77 2016–2025 Global Fund Data Service, PEPFAR Panorama Spotlight, PEPFAR results by province, PEPFAR testing by modality, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 3,565 (2025)
HIV-exposed infants tested within two months of birth Treatment cascade percent 9 2011–2024 UNAIDS AIDSinfo 94.0% (2024)
HIV-positive TB patients started or continued on ART Treatment cascade count 13 2015–2024 WHO Global Tuberculosis Programme 5 (2024)
Key-population people tested for HIV (count over the period) Treatment cascade count 24 2017–2024 Global Fund Data Service By population group, sex or age only, to 2024
New HIV diagnoses with a CD4 count below 200 Treatment cascade percent 5 2015–2020 UNAIDS AIDSinfo 25.0% (2020)
Newly diagnosed at HHS/CDC-funded partners (MER HTS_TST_POS) Treatment cascade count 6 2020–2025 PEPFAR results by funding agency 40 (2025)
Newly diagnosed at USAID-funded partners (MER HTS_TST_POS) Treatment cascade count 8 2018–2025 PEPFAR results by funding agency 14 (2025)
Newly diagnosed at other US-agency partners (MER HTS_TST_POS) Treatment cascade count 6 2020–2025 PEPFAR results by funding agency 13 (2025)
Newly enrolled on ART at HHS/CDC-funded partners (MER TX_NEW) Treatment cascade count 8 2018–2025 PEPFAR results by funding agency 83 (2025)
Newly enrolled on ART at USAID-funded partners (MER TX_NEW) Treatment cascade count 8 2018–2025 PEPFAR results by funding agency 6 (2025)
Newly enrolled on ART at other US-agency partners (MER TX_NEW) Treatment cascade count 6 2020–2025 PEPFAR results by funding agency 59 (2025)
Notified HIV cases, national case surveillance Treatment cascade count 51 2009–2025 PAHO Core Indicators, PAHO Interactive HIV Data Dashboard 238 (2025)
Number newly diagnosed HIV-positive (PEPFAR MER HTS_TST_POS) Treatment cascade count 52 2016–2025 PEPFAR Panorama Spotlight, PEPFAR results by province, PEPFAR testing by modality 67 (2025)
Number of PLHIV virally suppressed (VL<1000) Treatment cascade count 43 2017–2025 PEPFAR Panorama Spotlight, PEPFAR results by province 9,453 (2025)
Number of people on ART (PEPFAR MER TX_CURR) Treatment cascade count 124 2000–2025 Global Fund Data Service, PEPFAR Panorama Spotlight, PEPFAR results by province, UNAIDS AIDSinfo, WHO Global Health Observatory 14,716 (2025)
PMTCT ART coverage among pregnant women with HIV Treatment cascade percent 14 2010–2025 UNICEF HIV/AIDS dataset 95.0% (2025)
People newly diagnosed at a health facility Treatment cascade count 6 2020–2025 PEPFAR testing by modality 15 (2025)
People newly diagnosed through community outreach Treatment cascade count 8 2018–2025 PEPFAR testing by modality 12 (2025)
People newly enrolled on ART during the year Treatment cascade count 56 2016–2025 Global Fund Data Service, PEPFAR Panorama Spotlight, PEPFAR results by province, WHO Global Tuberculosis Programme 148 (2025)
People on ART at HHS/CDC-funded partners (MER TX_CURR) Treatment cascade count 8 2018–2025 PEPFAR results by funding agency 6,132 (2025)
People on ART at USAID-funded partners (MER TX_CURR) Treatment cascade count 8 2018–2025 PEPFAR results by funding agency 958 (2025)
People on ART at other US-agency partners (MER TX_CURR) Treatment cascade count 6 2020–2025 PEPFAR results by funding agency 4,328 (2025)
People on ART on a dolutegravir-based regimen Treatment cascade percent 12 2020–2025 PAHO Interactive HIV Data Dashboard By population group, sex or age only, to 2025
Pregnant women tested for HIV in antenatal care Treatment cascade percent 7 2015–2024 UNAIDS AIDSinfo 98.0% (2024)
Pregnant women with HIV who received ARVs for PMTCT Treatment cascade count 16 2010–2025 WHO Global Health Observatory 288 (2025)
TB patients recorded as HIV-positive Treatment cascade count 14 2015–2024 WHO Global Tuberculosis Programme 6 (2024)
TB patients with an HIV test result recorded Treatment cascade count 14 2015–2024 WHO Global Tuberculosis Programme 37 (2024)
Deaths from TB among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 3 (2024)
HIV prevalence among a key population Epidemic estimates percent 4 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
HIV prevalence, ages 15-49 Epidemic estimates percent 50 2000–2024 UNAIDS AIDSinfo, World Bank Open Data 1.1% (2024)
Incident TB cases among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 10 (2024)
New HIV infections Epidemic estimates count 510 2000–2024 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 1,100 (2024)
People living with HIV Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 28,000 (2025)
Key-population people reached by outreach (count over the period) Prevention and outreach count 24 2017–2024 Global Fund Data Service By population group, sex or age only, to 2024
Male condoms distributed in a year Prevention and outreach count 3 2022–2024 UNAIDS AIDSinfo 1,330,420 (2024)
People receiving PrEP Prevention and outreach count 17 2022–2025 Global Fund Data Service, PEPFAR Panorama Spotlight, PEPFAR results by province, UNAIDS AIDSinfo 54 (2025)
Estimated pregnant women with HIV needing ARVs for PMTCT Population denominators count 14 2010–2025 WHO Global Health Observatory 500 (2025)
Estimated size of a key population Population denominators count 4 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Total population Population denominators count 26 2000–2025 World Bank Open Data 2,837,077 (2025)
Share of HIV-exposed infants who acquire HIV — percent 13 2010–2022 UNICEF HIV/AIDS dataset 5.5% (2022)

Every row shown on the Jamaica page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.